Chronic Kidney Disease and Cerebrovascular Disease

Dearbhla Kelly(John Radcliffe Hospital), Manish M. Sood(Ottawa Hospital), Ḱazunori Toyoda(National Cerebral and Cardiovascular Center), Gregory Y.H. Lip(Medical University of Białystok), Patrick B. Mark(Queen Elizabeth University Hospital), Michael Cheung(National Kidney Foundation), Holger Reinecke(University Hospital Münster), Charles A. Herzog, Mark J. Sarnak(Tufts Medical Center), Wolfram Doehner(Deutsches Herzzentrum der Charité), Christopher X. Wong(Royal Adelaide Hospital), Kirsten L. Johansen, Zanfina Ademi(Monash University)
Stroke
June 3, 2021
10.1161/strokeaha.120.029680
Cited by 142

Related Papers

Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
|The Lancet|2018|5k
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
|Circulation|2003|3.8k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
|The Lancet|2014|2.7k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k